Acute pediatric hyperammonemia: current diagnosis and management strategies

Nadia Savy,1 David Brossier,2 Catherine Brunel-Guitton,1 Laurence Ducharme-Crevier,1 Geneviève Du Pont-Thibodeau,1 Philippe Jouvet1 1Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada; 2Department of Pediatrics, Pediatric Intensive Care Unit, CHU Ca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/8f51fa196350445096f62770cdd57065
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f51fa196350445096f62770cdd57065
record_format dspace
spelling oai:doaj.org-article:8f51fa196350445096f62770cdd570652021-12-02T06:59:54ZAcute pediatric hyperammonemia: current diagnosis and management strategies1179-1535https://doaj.org/article/8f51fa196350445096f62770cdd570652018-09-01T00:00:00Zhttps://www.dovepress.com/acute-pediatric-hyperammonemia-current-diagnosis-and-management-strate-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Nadia Savy,1 David Brossier,2 Catherine Brunel-Guitton,1 Laurence Ducharme-Crevier,1 Geneviève Du Pont-Thibodeau,1 Philippe Jouvet1 1Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada; 2Department of Pediatrics, Pediatric Intensive Care Unit, CHU Caen, Caen, France Abstract: Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. Keywords: pediatrics, critical care, hyperammonemia, sodium phenylacetate, sodium benzoate, hemodialysisSavy NBrossier DBrunel-Guitton CDucharme-Crevier LDu Pont-Thibodeau GJouvet PDove Medical PressarticlePediatricsCritical Carehyperammonemiasodium phenylacetatesodium benzoatehemodialysis.Diseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 10, Pp 105-115 (2018)
institution DOAJ
collection DOAJ
language EN
topic Pediatrics
Critical Care
hyperammonemia
sodium phenylacetate
sodium benzoate
hemodialysis.
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Pediatrics
Critical Care
hyperammonemia
sodium phenylacetate
sodium benzoate
hemodialysis.
Diseases of the digestive system. Gastroenterology
RC799-869
Savy N
Brossier D
Brunel-Guitton C
Ducharme-Crevier L
Du Pont-Thibodeau G
Jouvet P
Acute pediatric hyperammonemia: current diagnosis and management strategies
description Nadia Savy,1 David Brossier,2 Catherine Brunel-Guitton,1 Laurence Ducharme-Crevier,1 Geneviève Du Pont-Thibodeau,1 Philippe Jouvet1 1Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada; 2Department of Pediatrics, Pediatric Intensive Care Unit, CHU Caen, Caen, France Abstract: Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. Keywords: pediatrics, critical care, hyperammonemia, sodium phenylacetate, sodium benzoate, hemodialysis
format article
author Savy N
Brossier D
Brunel-Guitton C
Ducharme-Crevier L
Du Pont-Thibodeau G
Jouvet P
author_facet Savy N
Brossier D
Brunel-Guitton C
Ducharme-Crevier L
Du Pont-Thibodeau G
Jouvet P
author_sort Savy N
title Acute pediatric hyperammonemia: current diagnosis and management strategies
title_short Acute pediatric hyperammonemia: current diagnosis and management strategies
title_full Acute pediatric hyperammonemia: current diagnosis and management strategies
title_fullStr Acute pediatric hyperammonemia: current diagnosis and management strategies
title_full_unstemmed Acute pediatric hyperammonemia: current diagnosis and management strategies
title_sort acute pediatric hyperammonemia: current diagnosis and management strategies
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/8f51fa196350445096f62770cdd57065
work_keys_str_mv AT savyn acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT brossierd acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT brunelguittonc acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT ducharmecrevierl acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT dupontthibodeaug acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT jouvetp acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
_version_ 1718399646959665152